Latest

Will PRESERVE Trial Results Shift Practice in Renal Prophylaxis?Results of the large trial, unveiled at AHA 2017, appear indisputable, but will prophylaxis with sodium bicarb and acetylcysteine yield ground?
5 Stubborn Statin Myths vs Data that Refute ThemAt AHA.17, Dr Rory Collins offered large-scale trial data to help dispel dangerous disinformation still circulating about the effects of statins.
2017 ACC/AHA Hypertension Guidelines: Case StudyClick through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.
Cardiologists Talk Concrete Application of Artificial IntelligenceTwo cardiologists respected for their technological expertise took the concept of AI from blue sky to concrete clinical examples at AHA 2017.
New 2017 ACC/AHA Hypertension Guidelines, At-a-GlanceA shift to earlier intervention and emphasis on basics like proper BP measurement and intensive lifestyle change are the key revisions.
Evolocumab Impact Significant in Patients with PADLowering LDL-C levels in FOURIER trial patients with PAD had a significant impact on both MACE and MALE.
Selexipag Delays PAH Progression in Patients with Connective Tissue DiseaseResults of a subgroup analysis from the GRIPHON trial are promising for a hard-to-treat population.
New Biomarker Could Improve ARDS, AHF DiagnosisA biomarker of myocardial strain and inflammation may be able to discriminate between two similar pulmonary emergencies.
Quiz: 2017 ACC/AHA/HFSA Update to 2013 HF GuidelinesTest your recall of the most recent amendments to the heart failure guidelines on prevention, treatment of hypertension, and comorbidities.
Methamphetamine-associated PAH: First Prospective Cohort StudyMethamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.